» Articles » PMID: 17159101

Diabetes is Related to Cerebral Infarction but Not to AD Pathology in Older Persons

Overview
Journal Neurology
Specialty Neurology
Date 2006 Dec 13
PMID 17159101
Citations 143
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine the potential relation of diabetes to common neuropathologic causes of dementia, cerebral infarction and Alzheimer disease (AD) neuropathology.

Methods: Subjects were 233 older Catholic clergy in the Religious Orders Study, who underwent detailed annual evaluations, including neuropsychological testing, and brain autopsy at time of death (mean age 86 years, 45% men). Diabetes was identified by annual direct medication inspection and history. Cognitive function proximate to death was summarized into five cognitive domains, based on 19 neuropsychological tests. Macroscopic cerebral infarctions were recorded from 1 cm coronal slabs. Neuritic plaques, diffuse plaques, and neurofibrillary tangles were counted in Bielschowsky silver-stained sections and summarized to yield composite measures of neuritic plaques, diffuse plaques, tangles, and overall AD pathology. We also used immunohistochemistry with antibodies to amyloid-beta and PHF-tau to obtain quantitative measures of amyloid burden and neurofibrillary tangle density. Multiple logistic and linear regression analyses were used to examine the relation of diabetes to cerebral infarctions and AD pathology, controlling for age, sex, and education.

Results: AD pathology was related to all five cognitive domains (p < 0.01) and infarctions were related to perceptual speed (p < 0.001). Diabetes (present in 15% subjects) was associated with an increased odds of infarction (OR = 2.47, 95% CI: 1.16, 5.24). Diabetes was not related to global AD pathology score, or to specific measures of neuritic plaques, diffuse plaques or tangles, or to amyloid burden or tangle density.

Conclusion: We found a relation between diabetes and cerebral infarction but not between diabetes and Alzheimer disease pathology in older persons.

Citing Articles

Insulin signaling disruption exacerbates memory impairment and seizure susceptibility in an epilepsy model with Alzheimer's disease-like pathology.

Alves S, Servilha-Menezes G, Rossi L, Cortes de Oliveira J, Grigorio-de-SantAna M, Sebollela A J Neural Transm (Vienna). 2025; .

PMID: 39987343 DOI: 10.1007/s00702-025-02896-1.


Association of late-life variability in hemoglobin A1C with postmortem neuropathologies.

Biswas R, Capuano A, Mehta R, Bennett D, Arvanitakis Z Alzheimers Dement. 2025; 21(2):e14471.

PMID: 39968681 PMC: 11863718. DOI: 10.1002/alz.14471.


Review of Associations of Diabetes and Insulin Resistance With Brain Health in Three Harmonised Cohort Studies of Ageing and Dementia.

Biswas R, Capuano A, Mehta R, Barnes L, Bennett D, Arvanitakis Z Diabetes Metab Res Rev. 2025; 41(1):e70032.

PMID: 39873127 PMC: 11774135. DOI: 10.1002/dmrr.70032.


Brain phosphoproteomic analysis identifies diabetes-related substrates in Alzheimer's disease pathology in older adults.

Capuano A, Sarsani V, Tasaki S, Mehta R, Li J, Ahima R Alzheimers Dement. 2024; 21(2):e14460.

PMID: 39732516 PMC: 11848201. DOI: 10.1002/alz.14460.


Stem cell therapy in Alzheimer's disease: current status and perspectives.

Ou C, Xue W, Liu D, Ma L, Xie H, Ning K Front Neurosci. 2024; 18:1440334.

PMID: 39640295 PMC: 11618239. DOI: 10.3389/fnins.2024.1440334.